Biocon Ltd. (BIOCON) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 201791, "name": "Biocon", "stock_name": "Biocon", "full_name": "Biocon Ltd.", "name_url": "stocks-analysis/biocon", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "416.15", "chg": -4.5, "chgp": "-1.07%", "dir": -1, "prev_price": "420.65", "mcapval": "68,297.00 Cr", "mcap": "Mid Cap", "scripcode": 532523, "symbol": "BIOCON", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE376G01013", "curr_date": "Jun 25, 03:30 PM", "curr_time": "11:02 AM", "last_traded_at": "Jun 25, 03:30 PM IST", "bse_nse_vol": "24.23 lacs", "exc_status": "Active", "traded_date": "Jun 25, 2026", "traded_date_str": "2026 06 25", "score": "", "scoreText": "", "Live": 0, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biocon-201791-1&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "HT", "url": "https://www.marketsmojo.com/mojopro/strategy/1", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biocon-201791-1&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Biocon Ltd Sees Sharp Open Interest Surge Signalling Potential Market Shift", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-sharp-open-interest-surge-signalling-potential-market-shift-4070683", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BioconLtd_oi_spurts_by_underlying_4070683.png", "date": "2026-06-24 15:00:13", "description": "Biocon Ltd., a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased investor participation and evolving market positioning. This development comes amid a backdrop of steady price performance and rising liquidity, suggesting potential directional bets by market participants." }, { "title": "Biocon Ltd Sees Significant Open Interest Surge Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-significant-open-interest-surge-amid-mixed-market-signals-4070618", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BioconLtd_oi_spurts_by_underlying_4070618.png", "date": "2026-06-24 14:00:13", "description": "Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.66% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a slight dip in the stock price, the underlying volume and futures data suggest evolving directional bets that merit close attention from investors and analysts alike." }, { "title": "Biocon Ltd. is Rated Buy by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/biocon-ltd-is-rated-buy-by-marketsmojo-4068886", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BioconLtd_mojoScore_4068886.png", "date": "2026-06-23 10:10:54", "description": "Biocon Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 20 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 June 2026, providing investors with the most up-to-date insight into the company’s performance and outlook." }, { "title": "Biocon Ltd. is Rated Buy by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/biocon-ltd-is-rated-buy-by-marketsmojo-4048843", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BioconLtd_mojoScore_4048843.png", "date": "2026-06-12 10:10:41", "description": "Biocon Ltd. is rated Buy by MarketsMOJO, with this rating last updated on 20 May 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 12 June 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing." }, { "title": "Biocon Ltd. is Rated Buy by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/biocon-ltd-is-rated-buy-by-marketsmojo-4026050", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BioconLtd_mojoScore_4026050.png", "date": "2026-06-01 10:10:35", "description": "Biocon Ltd. is rated 'Buy' by MarketsMOJO, with this rating last updated on 20 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Biocon Ltd’s Subtle 0.46% Dip Masks Key Derivatives Surge and 52-Week High", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltds-subtle-046-dip-masks-key-derivatives-surge-and-52-week-high-4024567", "imagepath": "", "date": "2026-05-31 13:02:30", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Significant open interest surge amid mixed price action</p>\n <p><strong>26 May:</strong> New 52-week high reached at Rs.440.3</p>\n <p><strong>27 May:</strong> Price correction with heavy volume</p>\n <p><strong>29 May:</strong> Week closes at Rs.428.25 (-0.46%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.430.25</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.428.25</div><div class=\"stat-change negative\">-0..." }, { "title": "Broad-Based Technical Strength Lifts Biocon Ltd. to 52-Week High of Rs 440.3", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-hits-new-52-week-high-at-rs4403-mark-4013758", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BioconLtd_priceRelatedfactors_4013758.png", "date": "2026-05-26 12:10:07", "description": "With a decisive surge to Rs 440.3 on 26 Jun 2026, Biocon Ltd. has reached a fresh 52-week high, extending its impressive 31.79% return over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades near its recent peaks." }, { "title": "Biocon Ltd Sees Significant Open Interest Surge Amid Mixed Price Action", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-significant-open-interest-surge-amid-mixed-price-action-4011017", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BioconLtd_oi_spurts_by_underlying_4011017.png", "date": "2026-05-25 15:00:09", "description": "Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 13.5% increase in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning despite a modest price decline over recent sessions." }, { "title": "Biocon Ltd Sees Significant Open Interest Surge Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/biocon-ltd-sees-significant-open-interest-surge-amid-mixed-market-signals-4010935", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BioconLtd_oi_spurts_by_underlying_4010935.png", "date": "2026-05-25 14:00:09", "description": "Biocon Ltd., a mid-cap leader in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 11.05% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest decline in the stock price over recent sessions, the spike in OI alongside robust volume patterns suggests strategic directional bets are being placed, warranting close attention from market participants and analysts alike." } ], "total": 5844, "sid": "201791", "stock_news_url": "https://www.marketsmojo.com/news/biocon-201791" }, "announcements": [ { "details": "Biocon Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates", "source": "NSE", "caption": "Biocon Limited - Analysts/Institutional Investor Meet/Con. Call Updates", "datetime": "09-Dec-2019" }, { "details": "Biocon Limited has informed the Exchange regarding a press release dated December 02, 2019, titled \"Biocon and Mylan Launch Trastuzumab Biosimilar, Ogivri (trastuzumab-dkst), in the U.S.\".", "source": "NSE", "caption": "Biocon Limited - Press Release", "datetime": "03-Dec-2019" }, { "details": "Biocon Limited has informed the Exchange regarding a press release dated November 27, 2019, titled \"", "source": "NSE", "caption": "Biocon Limited - Press Release", "datetime": "27-Nov-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Biocon Ltd. has declared <strong>10%</strong> dividend, ex-date: 03 Jul 26", "dt": "2026-07-03", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Biocon Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 12 Jun 19", "dt": "2019-06-12", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: Significant open interest surge amid mixed price action

26 May: New 52-week high reached at Rs.440.3

27 May: Price correction with heavy volume

29 May: Week closes at Rs.428.25 (-0.46%)

Read full news article

Broad-Based Technical Strength Lifts Biocon Ltd. to 52-Week High of Rs 440.3

2026-05-26 12:10:07

With a decisive surge to Rs 440.3 on 26 Jun 2026, Biocon Ltd. has reached a fresh 52-week high, extending its impressive 31.79% return over the past year. This milestone comes amid a backdrop of strong technical momentum and a market environment where the Sensex trades near its recent peaks.

Read full news article

Biocon Ltd Sees Significant Open Interest Surge Amid Mixed Price Action

2026-05-25 15:00:09

Biocon Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 13.5% increase in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning despite a modest price decline over recent sessions.

Read full news article

Biocon Ltd Sees Significant Open Interest Surge Amid Mixed Market Signals

2026-05-25 14:00:09

Biocon Ltd., a mid-cap leader in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 11.05% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a modest decline in the stock price over recent sessions, the spike in OI alongside robust volume patterns suggests strategic directional bets are being placed, warranting close attention from market participants and analysts alike.

Read full news article